Shkreli has been experimenting with bitcoin in addition to his attempted comeback to the pharmaceutical sector. Martin Shkreli Inu, a cryptocurrency affiliated with his new firm, Druglike, was established. However, just two weeks after its introduction, the token dropped more than 72% to $0.00000678, and Shkreli blamed the failure on “hacking.”
Regardless of whether the cryptocurrency succeeds or fails, it is evident that Shkreli is not authorised by the court to create any company even indirectly associated with a medicine or prescription medications. The FTC claims that Shkreli failed to file compliance reports and violated a “clear and unequivocal” court order by attempting to launch Druglike.
